RELATES TO:
KRS
218A.205(3),
313.060,
313.085,
422.317,
42 U.S.C.
300ee-2 note
NECESSITY, FUNCTION, AND CONFORMITY:
KRS
313.060(1) requires the
board to promulgate administrative regulations relating to dental practices
that shall include minimal requirements for documentation and Centers for
Disease Control and Prevention compliance.
42 U.S.C.
300ee-2 note requires each state to institute
the guidelines issued by the United States Centers for Disease Control and
Prevention or guidelines that are equivalent to those promulgated by the
Centers for Disease Control and Prevention concerning recommendations for
preventing the transmission of the human immunodeficiency virus and the
hepatitis B virus during exposure-prone invasive procedures.
KRS
218A.205(3)(a) and (b)
require the board, in consultation with the Kentucky Office of Drug Control
Policy, to establish mandatory prescribing and dispensing standards related to
controlled substances. This administrative regulation establishes requirements
for preventing the transmission of the human immunodeficiency virus and the
hepatitis B virus during exposure-prone invasive procedures and includes
minimal requirements for documentation and Centers for Disease Control and
Prevention compliance. This administrative regulation also establishes
mandatory prescribing and dispensing standards related to controlled
substances.
Section 1. Applicability.
A dentist who is authorized to prescribe, dispense or administer a controlled
substance shall comply with the standards of acceptable and prevailing dental
practice for prescribing, dispensing or administering a controlled substance
established in this administrative regulation.
Section 2. Professional Standards for
Documentation of Dental Patients.
(1) Each
patient's dental records shall be kept by the dentist for a minimum of:
(a) Seven (7) years from the date of the
patient's last treatment;
(b) Seven
(7) years after the patient's eighteenth birthday, if the patient was seen as a
minor; or
(c) Two (2) years
following the patient's death.
(2) Each dentist shall comply with
KRS
422.317 regarding the release of patient
records.
(3) The dentist shall keep
accurate, readily accessible, and complete records which include:
(a) The patient's name;
(b) The patient's date of birth;
(c) The patient's medical history and
documentation of the physical exam of the oral and perioral tissues;
(d) The date of treatment;
(e) The areas to be treated;
(f) The material used in treatment;
(g) Local or general anesthetic used, route
of administration, and the amount;
(h) Sedation medications used, the amount,
monitoring techniques, and the names of qualified personnel that monitor the
patient;
(i) Diagnostic,
therapeutic, and laboratory results, if any;
(j) The findings and recommendations of the
dentist and a description of each evaluation or consultation, if any;
(k) Treatment objectives;
(l) Any and all treatments performed and
provided;
(m) All medications,
including date, type, dosage, and quantity prescribed or dispensed;
and
(n)Any post treatment
instructions.
(4) Prior
to prescribing or administering a Schedule II or III controlled substance, the
dentist shall obtain the signature of the patient or a legal guardian on a
consent form authorizing the treatment plan, including the use of controlled
substances.
Section 3.
Prescribing and Administration of Controlled Substances.
(1) In accordance with
KRS
313.035, a dentist may prescribe, dispense,
and administer any non-controlled drug necessary within the scope of the
dentist's practice if the dentist is licensed pursuant to KRS Chapter
313.
(2) In accordance with
KRS
313.035, a dentist may administer and
prescribe controlled substances necessary within the scope of the dentist's
practice if the dentist:
(a) Has obtained a
registration from the Drug Enforcement Administration; and
(b) Has enrolled with and utilizes the
Kentucky All Schedule Prescription Electronic Reporting System as required by
KRS
218A.202.
(3) A dentist shall not compound any
scheduled drugs or dispense controlled substances for use by the patient
outside the office setting.
(4) A
dentist shall obtain and document all relevant information in a patient's
medical and dental records in a legible manner and in sufficient detail to
enable the board to determine whether the dentist is conforming to professional
standards.
(5) Prior to the initial
prescribing or administration of a Schedule II or III controlled substance,
each dentist shall:
(a) Obtain and review a
KASPER report for the twelve (12) month period immediately preceding the
patient encounter and appropriately utilize that data in the evaluation and
treatment of the patient.
(b)
Document relevant information in the patient's record;
(c) Consider the available information to
determine if it is medically appropriate and safe to administer or prescribe a
controlled substance;
(d) Obtain a
complete medical history and conduct a physical examination of the oral or
maxillofacial area of the patient and document the information in the patient's
medical record;
(e) Make a written
treatment plan stating the objectives of the treatment and further diagnostic
examinations required;
(f) Discuss
the risks and benefits of the use of controlled substances with the patient,
the patient's parent if the patient is an unemancipated minor child, or the
patient's legal guardian or health care surrogate, including the risk of
tolerance and drug dependence; and
(g) Obtain written consent for the
treatment.
(6) Pursuant
to
KRS
218A.172, the requirements set forth within
this section shall not apply when prescribing or administering a controlled
substance:
(a) As part of the patient's
hospice or end of life treatment;
(b) To a patient admitted to a licensed
hospital as an inpatient, or observation patient, during and as part of a
normal and expected part of the patient's course of care at that
hospital.
(c) For the treatment of
pain associated with cancer or with the treatment of cancer;
(d) As necessary to treat a patient in an
emergency situation; or
(e) To a
patient admitted to a long-term care facility.
(7) A dentist shall not issue a prescription
for more than a three (3) day supply of a Schedule II or III controlled
substance to treat pain as an acute medical condition unless the following
conditions have been met:
(a) The dentist, in
his or her professional judgment, believes that more than a three (3) day
supply of a Schedule II or III controlled substance is medically necessary to
treat the patient's pain as an acute medical condition;
(b) The dentist has documented in the
patient's dental record the acute medical condition and lack of alternative
treatment options which justifies deviation from the three (3) day supply limit
established in this subsection; and
(c) The patient and the dentist have attested
by signature in the patient's dental record that alternative pain relief
methods using non-opioid medications were explained to the patient and that the
patient understands the risk of dependency when prescribed more than a three
(3) day supply of a Schedule II or III controlled substance. This may occur:
1. During, and in addition to, the patient's
original consultation and consent process as described in subsection (5) of
this section; or
2. As part of a
follow-up consultation after the initial three (3) day supply has been
prescribed.
(d) A
dentist licensed in Kentucky shall not act to avoid the three (3) day supply
limit established in subsection (4) of this section by prescribing or
administering a Schedule II or III controlled substance to a patient on
consecutive or multiple occasions.
(8) A dentist may provide one (1) refill
within thirty (30) days of the initial prescription for the same controlled
substance for the same amount or less or prescribe a lower schedule drug for
the same amount without a clinical reevaluation of the patient by the
dentist.
(9) A patient who requires
additional prescriptions for a controlled substance shall be clinically
reevaluated by the dentist, and the provisions of this section for the
prescription of controlled substances shall be followed. If the course of
treatment extends beyond three (3) months, the dentist shall obtain and review
a new KASPER report. The dentist shall provide any new information about the
treatment and modify or terminate treatment as appropriate.
(10) Any violation of this section shall be
considered a violation of
KRS
218A.205(3),
KRS
313.060, and
KRS
313.085, and shall constitute a legal basis
for disciplinary action pursuant to
KRS
313.035.
Section 4. Penalties and Investigations.
(1) A licensee convicted of a felony offense
related to a controlled substance shall, at a minimum, be banned from
prescribing or dispensing a controlled substance.
(2) A licensee convicted of a misdemeanor
offense relating to the prescribing of a controlled substance shall, at a
minimum, have a five (5) year ban from prescribing or dispensing a controlled
substance.
(3) A licensee
disciplined by a licensing board of another state relating to the improper,
inappropriate, or illegal prescribing or dispensing of controlled substances
shall, at a minimum, have the same disciplinary action imposed by this state or
the disciplinary action prescribed in subsection (1) or (2) of this section,
whichever is greater.
(4) A
licensee who is disciplined in another state or territory for an act or
omission which would constitute a violation of Section 4 of this administrative
regulation and fails to notify the board in writing of the disciplinary action
within thirty (30) days of the finalization of the action shall be subject to a
fine of $1,000 for each failure to report.
(5) If a licensee has been convicted of or
has entered a plea of guilt, an Alford plea, or a plea for nolo contendere to
any felony offense relating to a controlled substance; has successfully
participated in and completed a diversion program; and whose case has been
dismissed and the record of that offense expunged; the board may, in its
discretion, reinstate the licensee's prescribing and dispensing privileges
contingent upon the licensee entering into an agreed order with terms and
conditions deemed necessary by the board to implement a minimum five (5) year
period of probation.
(6) The board
may privately admonish a licensee who fails to register for an account with the
Kentucky All Schedule Prescription Electronic Reporting System or who fails to
meet the requirements of this administrative regulation. If a licensee is
privately admonished by the board under this subsection, the licensee shall be
given no more than thirty (30) days to become compliant after which time the
dentist may be fined up to $10,000 for failure to be registered with KASPER. A
licensee who fails to utilize KASPER prior to prescribing a controlled
substance may be fined up to $250 per incident by the board.
(7) The Law Enforcement Committee of the
Board shall produce a charging decision on the complaint within 120 days of the
receipt of the complaint, unless:
(a) An
investigation pertaining to the prescribing or dispensing of a controlled
substance make it impossible to timely present the grievance to the designated
review committee, person, or Law Enforcement Committee; or
(b) The board holds a complaint pertaining to
the prescribing or dispensing of a controlled substance in abeyance to permit a
law enforcement agency, upon the agency's request, to perform or complete an
investigation.
(c) If a charging
decision is not produced within 120 days of the date of receipt of the
complaint under this subsection, the investigative report shall plainly state
the circumstances pursuant to paragraphs (a) and (b) of this subsection that
prevented the timely production of the charging decision.
Section 5. Infection Control
Compliance.
(1) Each licensed dentist in the
Commonwealth of Kentucky shall:
(a) Adhere to
the standard precautions outlined in the Guidelines for Infection Control in
Dental Health-Care Settings published by the Centers for Disease Control and
Prevention; and
(b) Ensure that any
person under the direction, control, supervision, or employment of a licensee
whose activities involve contact with patients, teeth, blood, body fluids,
saliva, instruments, equipment, appliances, or intraoral devices adheres with
those same standard precautions.
(2) The board or its designee shall perform
an infection control inspection of a dental practice or office utilizing the
Infection Control Inspection Checklist, if the board and its staff become aware
of a violation, or a reliable allegation of a violation, of the Guidelines for
Infection Control in Dental Health-Care Settings which may pose imminent public
risk.
(3)
(a) Any dentist who is found deficient upon
an initial infection control inspection shall have thirty (30) days to be in
compliance with the guidelines and submit a written plan of correction to the
board.
(b) The dentist may receive
a second inspection after the thirty (30) days have passed and may be required
to pay reasonable expenses to the board or its designee to conduct the
inspection, not to exceed the amount of the fine required for failure of a
second inspection pursuant to this chapter.
(c) If the dentist fails the second
inspection, he or she shall be immediately temporarily suspended pursuant to
KRS
313.085 until proof of compliance is provided
to the board and the dentist pays the fine as prescribed in this
chapter.
(4) Any
licensed dentist, licensed dental hygienist, or dental assistant who performs
invasive procedures may seek counsel from the board if he or she tests
seropositive for the human immunodeficiency virus or the hepatitis B
virus.
(5) Upon the request of a
licensee or registrant, the executive director of the board or designee shall
convene a confidential expert review panel to offer counsel regarding under
what circumstances, if any, the individual may continue to perform invasive
procedures.
Section 6.
Termination of a Patient-Doctor Relationship. In order for a licensed dentist
to terminate the patient-doctor relationship, the dentist shall:
(1) Provide written notice to the patient of
the termination;
(2) Provide
emergency treatment for the patient for thirty (30) days from the date of
termination; and
(3) Retain a copy
of the letter of termination in the patient records.
Section 7. Incorporation by Reference.
(1) The following material is incorporated by
reference:
(a) "Guidelines for Infection
Control in Dental Health-Care Settings", December 2003, or the latest version
issued by the Centers for Disease Control on Infection Control in Dental Health
Care Setting; and
(b) "Infection
Control Inspection Checklist", July 2010.
(2) This material may be inspected, copied,
or obtained, subject to applicable copyright law, at the Kentucky Board of
Dentistry, 312 Whittington Parkway, Suite 101, Louisville, Kentucky 40222,
Monday through Friday, 8 a.m. through 4:30 p.m. This material is also available
on the board's Web site at
http://dentistry.ky.gov.